+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Shionogi Inc - Strategic SWOT Analysis Review

Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets products for various therapeutic areas such as pain, anti-infectives, women's health, pediatrics, cardiovascular, and others. Shionogi offers its products in various formulations such as tablets, oral suspensions (solutions), lotions, chewable tablets, capsules, and injections. Some of the company’s key branded products include Fortamet, and Methylin, among others. Shionogi is headquartered in Florham Park, New Jersey, the US.

Shionogi Inc Key Recent Developments

  • Jun 24, 2024: Shionogi Appoints David Benadon Senior Vice President, Chief Human Resources Officer
  • Feb 05, 2024: Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramon Polo as Senior Vice President, Head of Regulatory Affairs

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Shionogi Inc - Key Facts
  • Shionogi Inc - Key Employees
  • Shionogi Inc - Key Employee Biographies
  • Shionogi Inc - Major Products and Services
  • Shionogi Inc - History
  • Shionogi Inc - Company Statement
  • Shionogi Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Shionogi Inc - Business Description
  • Shionogi Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Shionogi Inc - Strengths
  • Shionogi Inc - Weaknesses
  • Shionogi Inc - Opportunities
  • Shionogi Inc - Threats
  • Shionogi Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Shionogi Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jun 24, 2024: Shionogi Appoints David Benadon Senior Vice President, Chief Human Resources Officer
  • Feb 05, 2024: Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramon Polo as Senior Vice President, Head of Regulatory Affairs
Section 5 - Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Shionogi Inc, Key Facts
  • Shionogi Inc, Key Employees
  • Shionogi Inc, Key Employee Biographies
  • Shionogi Inc, Major Products and Services
  • Shionogi Inc, History
  • Shionogi Inc, Subsidiaries
  • Shionogi Inc, Key Competitors
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Shionogi Inc, Recent Deals Summary
List of Figures
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Sumitomo Pharma America Inc
  • Sigilon Therapeutics Inc
  • SciClone Pharmaceuticals Holdings Ltd
  • EpiVax Inc
  • Ardelyx Inc